We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSTR icon
1251
Strategy Inc
MSTR
$34.1B
$16.3M 0.01%
245,320
+28,170
+13% +$1.67M
AMT icon
1252
CALL
American Tower
AMT
$80.8B
$16.3M 0.01%
59,600
+11,100
+23% +$2.83M
CHTR icon
1253
PUT
Charter Communications
CHTR
$17.3B
$16.2M 0.01%
22,500
+2,900
+15% +$1.95M
TOL icon
1254
Toll Brothers
TOL
$13.6B
$16.2M 0.01%
277,879
+105,684
+61% +$6.44M
PRFT
1255
DELISTED
Perficient Inc
PRFT
$16.1M 0.01%
200,708
-46,365
-19% -$3.27M
PENN icon
1256
PENN Entertainment
PENN
$2.75B
$16.1M 0.01%
210,986
+5,586
+3% +$481K
FEUL
1257
DELISTED
Credit Suisse FI Enhanced Europe 50 Exchange Traded Notes due May 11, 2028 Linked to the STOXX Europ
FEUL
$16.1M 0.01%
145,782
-3,000
-2% -$321K
AXON
1258
Axon Enterprise
AXON
$42.5B
$16.1M 0.01%
90,837
-2,671
-3% -$393K
FTI icon
1259
TechnipFMC
FTI
$28.1B
$16M 0.01%
1,793,532
-1,425,262
-44% -$12M
SYY icon
1260
PUT
Sysco
SYY
$40.8B
$16M 0.01%
+211,300
New +$17.1M
VWO icon
1261
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$16M 0.01%
293,901
+109,583
+59% +$5.84M
ON icon
1262
ON Semiconductor
ON
$31.8B
$15.9M 0.01%
416,211
-303,425
-42% -$11.9M
NTLA icon
1263
Intellia Therapeutics
NTLA
$1.49B
$15.9M 0.01%
98,277
+17,640
+22% +$1.37M
LRCX icon
1264
CALL
Lam Research
LRCX
$367B
$15.9M 0.01%
244,000
+111,000
+83% +$7.01M
ALTR
1265
DELISTED
Altair Engineering Inc
ALTR
$15.9M 0.01%
229,909
-3,805
-2% -$250K
GE icon
1266
CALL
GE Aerospace
GE
$374B
$15.9M 0.01%
242,951
-311,849
-56% -$20.8M
LYV icon
1267
Live Nation Entertainment
LYV
$40.6B
$15.8M 0.01%
179,056
-57,826
-24% -$4.96M
GILD icon
1268
PUT
Gilead Sciences
GILD
$162B
$15.8M 0.01%
229,900
-265,000
-54% -$17.7M
Y
1269
DELISTED
Alleghany Corp
Y
$15.8M 0.01%
23,737
+4,439
+23% +$3.05M
AZN icon
1270
AstraZeneca
AZN
$263B
$15.8M 0.01%
132,033
+85,042
+181% +$9.33M
AI icon
1271
CALL
C3.ai
AI
$1.43B
$15.7M 0.01%
244,100
+230,200
+1,656% +$14.3M
MOH icon
1272
Molina Healthcare
MOH
$10.2B
$15.7M 0.01%
61,227
-22,626
-27% -$5.68M
ENV
1273
DELISTED
ENVESTNET, INC.
ENV
$15.7M 0.01%
201,587
+33,555
+20% +$2.47M
INDA icon
1274
iShares MSCI India ETF
INDA
$6.89B
$15.7M 0.01%
355,215
+152,359
+75% +$6.53M
DQ
1275
Daqo New Energy
DQ
$823M
$15.7M 0.01%
235,345
-53,097
-18% -$3.82M

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.